Veradigm announces resignation of director Beth Altman due to health reasons

Veradigm (MDRX) announced that on January 28, Beth Altman stepped down from the company’s board of directors due to health reasons. “Her decision to resign was not the result of any disagreement with the company on any matter relating to the company’s operations, policies, or practices. Ms. Altman’s resignation has no impact on the company’s ongoing restatement of its 2022 financial statements. Altman has been a valued advisor since 2020 and, as Audit Committee Chair, has been instrumental in helping the Company navigate a challenging period. Following Altman’s resignation, the Board appointed Greg Garrison to the Audit Committee of the Board and as interim Chair of the Audit Committee. Garrison previously served as the Chair of the Audit Committee from May 2016 through June 2022,” Veradigm stated.